These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 33436815)

  • 1. Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice.
    Zhang W; Miikeda A; Zuckerman J; Jia X; Charugundla S; Zhou Z; Kaczor-Urbanowicz KE; Magyar C; Guo F; Wang Z; Pellegrini M; Hazen SL; Nicholas SB; Lusis AJ; Shih DM
    Sci Rep; 2021 Jan; 11(1):518. PubMed ID: 33436815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease.
    Gupta N; Buffa JA; Roberts AB; Sangwan N; Skye SM; Li L; Ho KJ; Varga J; DiDonato JA; Tang WHW; Hazen SL
    Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1239-1255. PubMed ID: 32212854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbial metabolite TMAO contributes to renal dysfunction in a mouse model of diet-induced obesity.
    Sun G; Yin Z; Liu N; Bian X; Yu R; Su X; Zhang B; Wang Y
    Biochem Biophys Res Commun; 2017 Nov; 493(2):964-970. PubMed ID: 28942145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The guanylate cyclase C agonist linaclotide ameliorates the gut-cardio-renal axis in an adenine-induced mouse model of chronic kidney disease.
    Nanto-Hara F; Kanemitsu Y; Fukuda S; Kikuchi K; Asaji K; Saigusa D; Iwasaki T; Ho HJ; Mishima E; Suzuki T; Suzuki C; Tsukimi T; Matsuhashi T; Oikawa Y; Akiyama Y; Kure S; Owada Y; Tomioka Y; Soga T; Ito S; Abe T
    Nephrol Dial Transplant; 2020 Feb; 35(2):250-264. PubMed ID: 31411705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbe-derived metabolite trimethylamine N-oxide accelerates fibroblast-myofibroblast differentiation and induces cardiac fibrosis.
    Yang W; Zhang S; Zhu J; Jiang H; Jia D; Ou T; Qi Z; Zou Y; Qian J; Sun A; Ge J
    J Mol Cell Cardiol; 2019 Sep; 134():119-130. PubMed ID: 31299216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
    Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
    Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonlethal Inhibition of Gut Microbial Trimethylamine N-oxide Production Improves Cardiac Function and Remodeling in a Murine Model of Heart Failure.
    Organ CL; Li Z; Sharp TE; Polhemus DJ; Gupta N; Goodchild TT; Tang WHW; Hazen SL; Lefer DJ
    J Am Heart Assoc; 2020 May; 9(10):e016223. PubMed ID: 32390485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbe-derived metabolite trimethylamine N-oxide induces cardiac hypertrophy and fibrosis.
    Li Z; Wu Z; Yan J; Liu H; Liu Q; Deng Y; Ou C; Chen M
    Lab Invest; 2019 Mar; 99(3):346-357. PubMed ID: 30068915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome.
    Li X; Su C; Jiang Z; Yang Y; Zhang Y; Yang M; Zhang X; Du Y; Zhang J; Wang L; Jiang J; Hong B
    NPJ Biofilms Microbiomes; 2021 Apr; 7(1):36. PubMed ID: 33863898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Colonization with Methanogenic Archaea Lowers Plasma Trimethylamine N-oxide Concentrations in Apolipoprotein e-/- Mice.
    Ramezani A; Nolin TD; Barrows IR; Serrano MG; Buck GA; Regunathan-Shenk R; West RE; Latham PS; Amdur R; Raj DS
    Sci Rep; 2018 Oct; 8(1):14752. PubMed ID: 30283097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
    Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
    mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism.
    Pathak P; Helsley RN; Brown AL; Buffa JA; Choucair I; Nemet I; Gogonea CB; Gogonea V; Wang Z; Garcia-Garcia JC; Cai L; Temel R; Sangwan N; Hazen SL; Brown JM
    Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1474-H1486. PubMed ID: 32330092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition.
    Lee J; Lee J; Kim K; Lee J; Jung Y; Hyeon JS; Seo A; Jin W; Weon B; Shin N; Kim S; Lim CS; Kim YS; Lee JP; Hwang GS; Yang SH
    Kidney Int; 2024 Jun; 105(6):1239-1253. PubMed ID: 38431216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.
    Romano KA; Vivas EI; Amador-Noguez D; Rey FE
    mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients.
    Xu KY; Xia GH; Lu JQ; Chen MX; Zhen X; Wang S; You C; Nie J; Zhou HW; Yin J
    Sci Rep; 2017 May; 7(1):1445. PubMed ID: 28469156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary Choline or Trimethylamine N-oxide Supplementation Does Not Influence Atherosclerosis Development in Ldlr-/- and Apoe-/- Male Mice.
    Aldana-Hernández P; Leonard KA; Zhao YY; Curtis JM; Field CJ; Jacobs RL
    J Nutr; 2020 Feb; 150(2):249-255. PubMed ID: 31529091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart Failure.
    Organ CL; Otsuka H; Bhushan S; Wang Z; Bradley J; Trivedi R; Polhemus DJ; Tang WH; Wu Y; Hazen SL; Lefer DJ
    Circ Heart Fail; 2016 Jan; 9(1):e002314. PubMed ID: 26699388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal Adenine-Induced Chronic Kidney Disease Programs Hypertension in Adult Male Rat Offspring: Implications of Nitric Oxide and Gut Microbiome Derived Metabolites.
    Hsu CN; Yang HW; Hou CY; Chang-Chien GP; Lin S; Tain YL
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33008046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choline and butyrate beneficially modulate the gut microbiome without affecting atherosclerosis in APOE*3-Leiden.CETP mice.
    Liu C; Li Z; Song Z; Fan X; Shao H; Schönke M; Boon MR; Rensen PCN; Wang Y
    Atherosclerosis; 2022 Dec; 362():47-55. PubMed ID: 36347649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blueberry intervention mitigates detrimental microbial metabolite trimethylamine N-oxide by modulating gut microbes.
    Satheesh Babu AK; Petersen C; Iglesias-Carres L; Paz HA; Wankhade UD; Neilson AP; Anandh Babu PV
    Biofactors; 2024; 50(2):392-404. PubMed ID: 37921575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.